Skip to main content

ORIGINAL RESEARCH article

Front. Oncol.

Sec. Neuro-Oncology and Neurosurgical Oncology

Volume 15 - 2025 | doi: 10.3389/fonc.2025.1551937

This article is part of the Research Topic Improving neurosurgical precision: leveraging technology for enhanced visualization and navigation of complex neuroanatomy View all 4 articles

Surgical and Clinical Impacts of Mixed Reality-Guided Glioblastoma Resection Versus Standard Neuronavigation

Provisionally accepted
Julien Haemmerli Julien Haemmerli 1*Samuel Khatchatourov Samuel Khatchatourov 2Etienne Chaboudez Etienne Chaboudez 1Leonard Roth Leonard Roth 3Abiram Sandralegar Abiram Sandralegar 2Insa Janssen Insa Janssen 1Denis Migliorini Denis Migliorini 1,2Karl Schaller Karl Schaller 1,2Philippe Bijlenga Philippe Bijlenga 1,2
  • 1 University Hospitals of Geneva, Geneva, Switzerland
  • 2 Faculty of Medicine, University of Geneva, Geneva, Geneva, Switzerland
  • 3 Université de Lausanne, Lausanne, Vaud, Switzerland

The final, formatted version of the article will be published soon.

    Glioblastomas (GBM) are typically treated with surgery and radio-chemotherapy, with patient survival often depending on the extent of tumor resection. This study compares outcomes of GBM surgery using 5-ALA, intraoperative neuroelectrophysiology, and neuro-navigation, either in a standard setting (STD) or enhanced by mixed reality (MR) guidance.This retrospective study included GBM patients who underwent resection at Geneva University Hospitals between 2015 and mid-2022, excluding biopsies and partial debulking. Primary outcomes included postoperative residual tumor volume (RV) based on postoperative contrast uptake on the MRI, while secondary outcomes were gross total resection (GTR), extent of resection (EOR), new postoperative deficits, overall survival (OS), progression-free survival (PFS), and Karnofsky performance scores. Confounding factors such as intraoperative monitoring and use of fluorescence were analyzed.Of 115 patients, 76 were in the STD group and 39 in the MR group, with comparable demographics. The MR group had significantly lower RV (median 0.01 cm³ vs. 0.34 cm³, p=0.008) and higher GTR rates (median 50% vs. 26.7%). EOR was also superior in the MR group (median 99.9% vs. 98.2%, p=0.002). New focal deficits occurred in 39% (STD) and 36% (MR) of cases (p=0.84). While median OS was not significantly different (475 vs. 375 days, p=0.63), median PFS was longer in the MR group (147 vs. 100 days, p=0.004).MR guidance improves the quality of tumor resection and enhances progression-free survival without increasing postoperative deficits, although it does not significantly impact overall survival.

    Keywords: Mixed reality, Oncologic neurosurgery, glioblastomas, GTR, Progression-free survival

    Received: 26 Dec 2024; Accepted: 04 Mar 2025.

    Copyright: © 2025 Haemmerli, Khatchatourov, Chaboudez, Roth, Sandralegar, Janssen, Migliorini, Schaller and Bijlenga. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Julien Haemmerli, University Hospitals of Geneva, Geneva, Switzerland

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

    Research integrity at Frontiers

    Man ultramarathon runner in the mountains he trains at sunset

    94% of researchers rate our articles as excellent or good

    Learn more about the work of our research integrity team to safeguard the quality of each article we publish.


    Find out more